Robert-Guroff M - Search Results

1

Alteration of V3 loop context within the envelope of human immunodeficiency virus type 1 enhances neutralization.

Robert-Guroff M, Louie A, Myagkikh M, Michaels F, Kieny MP, White-Scharf ME, Potts B, Grogg D, Reitz MS Jr. Robert-Guroff M, et al. J Virol. 1994 Jun;68(6):3459-66. doi: 10.1128/JVI.68.6.3459-3466.1994. J Virol. 1994. PMID: 7514675 Free PMC article.

2

Structure and expression of tat-, rev-, and nef-specific transcripts of human immunodeficiency virus type 1 in infected lymphocytes and macrophages.

Robert-Guroff M, Popovic M, Gartner S, Markham P, Gallo RC, Reitz MS. Robert-Guroff M, et al. J Virol. 1990 Jul;64(7):3391-8. doi: 10.1128/JVI.64.7.3391-3398.1990. J Virol. 1990. PMID: 2191150 Free PMC article.

3

The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope.

Wilson C, Reitz MS Jr, Aldrich K, Klasse PJ, Blomberg J, Gallo RC, Robert-Guroff M. Wilson C, et al. J Virol. 1990 Jul;64(7):3240-8. doi: 10.1128/JVI.64.7.3240-3248.1990. J Virol. 1990. PMID: 2352323 Free PMC article.

4

Generation of a neutralization-resistant variant of HIV-1 is due to selection for a point mutation in the envelope gene.

Reitz MS Jr, Wilson C, Naugle C, Gallo RC, Robert-Guroff M. Reitz MS Jr, et al. Cell. 1988 Jul 1;54(1):57-63. doi: 10.1016/0092-8674(88)90179-1. Cell. 1988. PMID: 2838179

5

Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker.

di Marzo Veronese F, Reitz MS Jr, Gupta G, Robert-Guroff M, Boyer-Thompson C, Louie A, Gallo RC, Lusso P. di Marzo Veronese F, et al. J Biol Chem. 1993 Dec 5;268(34):25894-901. J Biol Chem. 1993. PMID: 7503990 Free article.

6

Immune escape by human immunodeficiency virus type 1 from neutralizing antibodies: evidence for multiple pathways.

Watkins BA, Reitz MS Jr, Wilson CA, Aldrich K, Davis AE, Robert-Guroff M. Watkins BA, et al. J Virol. 1993 Dec;67(12):7493-500. doi: 10.1128/JVI.67.12.7493-7500.1993. J Virol. 1993. PMID: 7693973 Free PMC article.

7

Spontaneous reversion of human immunodeficiency virus type 1 neutralization-resistant variant HXB2thr582: in vitro selection against cytopathicity highlights gp120-gp41 interactive regions.

Stern TL, Reitz MS Jr, Robert-Guroff M. Stern TL, et al. J Virol. 1995 Mar;69(3):1860-7. doi: 10.1128/JVI.69.3.1860-1867.1995. J Virol. 1995. PMID: 7853527 Free PMC article.

8

An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.

Klasse PJ, McKeating JA, Schutten M, Reitz MS Jr, Robert-Guroff M. Klasse PJ, et al. Virology. 1993 Sep;196(1):332-7. doi: 10.1006/viro.1993.1484. Virology. 1993. PMID: 8356803

9

Resistance of human immunodeficiency virus type 1 to neutralization by natural antisera occurs through single amino acid substitutions that cause changes in antibody binding at multiple sites.

Watkins BA, Buge S, Aldrich K, Davis AE, Robinson J, Reitz MS Jr, Robert-Guroff M. Watkins BA, et al. J Virol. 1996 Dec;70(12):8431-7. doi: 10.1128/JVI.70.12.8431-8437.1996. J Virol. 1996. PMID: 8970964 Free PMC article.

10

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates.

Robert-Guroff M, Aldrich K, Muldoon R, Stern TL, Bansal GP, Matthews TJ, Markham PD, Gallo RC, Franchini G. Robert-Guroff M, et al. J Virol. 1992 Jun;66(6):3602-8. doi: 10.1128/JVI.66.6.3602-3608.1992. J Virol. 1992. PMID: 1374810 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

259 results

Search Page

Filters